Account Info
Log Out
English
Back
No matches yet
Operations too frequent. Please try again later.
Please check network settings and try again Refresh Refresh
Loading
History record delete
    Quotes All >
      News All >
        Log in to access Online Inquiry
        Back to the Top

        Top upgrades and downgrades on 4/6

        avatar
        Analysts Notebook wrote a column · 04/06/2022 19:01
        Upgrades
        $Banc of California(BANC.US)$: Raymond James Upgrades to Outperform from Market Perform - PT $22
        $Cullen/Frost Bankers(CFR.US)$: Raymond James Upgrades to Outperform from Market Perform
        $W.W. Grainger(GWW.US)$: Wolfe Research Upgrades to Outperform from Peerperform
        $Invitation Homes Inc(INVH.US)$: Evercore ISI Upgrades to Outperform from In Line - PT $46 (from $44)
        $PCB Bancorp(PCB.US)$: Raymond James Upgrades to Outperform from Market Perform - PT $25
        $PJT Partners(PJT.US)$: KBW Upgrades to Outperform from Market Perform - PT $79 (from $74)
        $Royalty Pharma(RPRX.US)$: Morgan Stanley Upgrades to Overweight from Equalweight - PT $48 (from $46)
        $Synchrony Financial(SYF.US)$: Piper Sandler Upgrades to Overweight from Neutral - PT $49 (from $48)
        $Synchrony Financial(SYF.US)$: Piper Sandler Upgrades to Overweight from Neutral - PT $49 (from $48)
        $Trex Co.(TREX.US)$: B.Riley Upgrades to Buy from Neutral - PT $88 (from $106)
        Downgrades
        $Ameriprise Financial(AMP.US)$: Piper Sandler Downgrades to Underweight from Neutral - PT $310 (from $325)
        $Banc of California(BANC.US)$: Raymond James Downgrades to Market Perform from Outperform
        $Builders FirstSource(BLDR.US)$: B.Riley Downgrades to Neutral from Buy - PT $71 (from $93)
        $bluebird bio(BLUE.US)$: Cowen Downgrades to Market Perform From Outperform
        $Bristol-Myers Squibb(BMY.US)$: Morgan Stanley Downgrades to Underweight from Equalweight - PT $64 (from $66)
        $Cano Health(CANO.US)$: Piper Sandler Downgrades to Underweight from Neutral - PT $5 (from $8.50)
        $Cullen/Frost Bankers(CFR.US)$: Raymond James Downgrades to Market Perform from Outperform
        $Gates Industrial(GTES.US)$: Wolfe Research Downgrades to Peerperform from Outperform
        $Hyzon Motors(HYZN.US)$: Canaccord Downgrades to Hold From Buy - PT $6 (from $12)
        $IMARA(IMRA.US)$: SVB Leerink Downgrades to Market Perform From Outperform - PT $1 From $31
        $Ingersoll Rand(IR.US)$: Wolfe Research Downgrades to Peerperform from Outperform
        $Jazz Pharmaceuticals(JAZZ.US)$: Goldman Sachs Downgrades to Neutral from Buy - PT $196 (from $202)
        $Jazz Pharmaceuticals(JAZZ.US)$: Goldman Sachs Downgrades to Neutral from Buy - PT $196 (from $202)
        $JetBlue Airways(JBLU.US)$: Raymond James Downgrades to Market Perform from Outperform
        $Kennametal(KMT.US)$: Loop Capital Downgrades to Hold from Buy
        $Moelis & Co(MC.US)$: KBW Downgrades to Market Perform from Outperform - PT $57 (from $70)
        $MarketAxess(MKTX.US)$: Raymond James Downgrades to Market Perform from Outperform
        $United Community Banks(UCBI.US)$: Raymond James Downgrades to Market Perform from Outperform - PT $42
        Initiated
        $Occidental Petroleum(OXY.US)$: Stifel initiates at Buy - PT $84
        $Upstart(UPST.US)$: Loop Capital initiates at Buy - PT $140
        $Abiomed(ABMD.US)$: Wolfe Research initiates at Peerperform - PT $330
        $Axonics(AXNX.US)$: Wolfe Research initiates at Outperform - PT $69
        $Axonics(AXNX.US)$: Wolfe Research initiates at Peerperform - PT $270
        $iRhythm Technologies(IRTC.US)$: Wolfe Research initiates at Underperform - PT $105
        $Intuitive Surgical(ISRG.US)$: Wolfe Research initiates at Peerperform - PT $315
        $LivaNova(LIVN.US)$: Wolfe Research initiates at Outperform - PT $95
        $Masimo(MASI.US)$: Wolfe Research initiates at Peerperform - PT $160
        $NeuroPace(NPCE.US)$: Wolfe Research initiates at Outperform - PT $13
        $Nevro(NVRO.US)$: Wolfe Research initiates at Underperform - PT $64
        $Nyxoah SA(NYXH.US)$: Wolfe Research initiates at Peerperform - PT $21
        $ResMed(RMD.US)$: Wolfe Research initiates at Outperform - PT $280
        $Sotera Health Company(SHC.US)$: Wolfe Research initiates at Outperform - PT $26
        $Silk Road Medical(SILK.US)$: Wolfe Research initiates at Outperform - PT $48
        $StoneCo(STNE.US)$: Wolfe Research initiates at Outperform - PT $275
        $ShockWave Medical(SWAV.US)$: Wolfe Research initiates at Outperform - PT $255
        $Affirm Holdings(AFRM.US)$: Stephens initiates at EqualWeight - PT $51
        $Fiserv(FISV.US)$: Stephens initiates at EqualWeight - PT $110
        $Fidelity National Information Services(FIS.US)$: Stephens initiates at Overweight - PT $125
        $Global Payments(GPN.US)$: Stephens initiates at Overweight - PT $170
        $PayPal(PYPL.US)$: Stephens initiates at EqualWeight - PT $135
        $Block(SQ.US)$: Stephens initiates at Overweight - PT $170
        $Arvinas(ARVN.US)$: Morgan initiates at Equalweight - PT $65
        $Atlantica Sustainable Infrastructure(AY.US)$: BMO Capital initiates at Market Perform - PT $37
        $Zentalis Pharmaceuticals(ZNTL.US)$: Wells Fargo initiates at Overweight - PT $67
        $QualTek Services(QTEK.US)$: Oppenheimer initiates at Outperform - PT $7
        $Gladstone Capital(GLAD.US)$: Raymond James initiates at Market Perform
        Disclaimer: Moomoo Technologies Inc. is providing this content for information and educational use only. Read more
        1
        5
        +0
        Translate
        Report
        735K Views
        Comment
        Sign in to post a comment